“The Center for International Blood and Marrow Transplant Research (CIBMTR) is a voluntary organization of basic and clinical scientists collaborating in an effort to address important issues in blood and marrow transplantation, …[which gathers] information on results of blood and marrow transplants. This information is used to guide clinical decisions and identify ways to improve transplant outcomes.” (http://www.ibmtr.org/home/mission.html; accessed 2/15/05)

Members of CIBMTR’s corporate membership program include:

• Aetna
• AIG Medical Excess
• AnorMED, Inc.
• Berlex Laboratories
• Biogen IDEC
• BlueCross and BlueShield Association
• Celgene Corporation
• Celmed Biosciences, Inc.
• Dynal Biotech, Inc.
• Edwards Lifesciences, LLC
• Enzon Pharmaceuticals, Inc.
• ESP Pharma, Inc.
• Fujisawa Healthcare, Inc.
• Gambro BCT, Inc.
• Milliman USA, Inc.
• Osiris Therapeutics, Inc.
• Pfizer, Inc.
• THERAKOS, a Johnson & Johnson Co.
• WellPoint Health Network